American Healthcare REIT (AHR) fundamentals: P/E, valuation, undervalued?

American Healthcare REIT · Real Estate · ref. ETF XLRE · price $56.48
Logo American Healthcare REITSee the full American Healthcare REIT (AHR) profile
In short — American Healthcare REIT trades at 84.3× earnings (P/E), 57.1× forward, with a net margin of 4.8 % and revenue growth of +25 %. Read: Cheap for the growth (P/E 57 for ~158% growth (PEG 0.4)).

Is American Healthcare REIT stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.

📈 1-year price
$56.48+32.2% over range
Aug 28, 25low $40.18 · high $57.72Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 9 analysts
Valuation : Cheap for the growth — P/E 57 for ~158% growth (PEG 0.4)

Valuation

84.3
P/E (price/earnings)
57.1
Forward P/E
0.54
PEG
3.0
Price/book (P/B)
$12.3B
Market cap
0.67
EPS

Profitability & growth

4.8 %
Net margin
+25 %
Revenue growth
+158 %
Earnings growth
$1.6B
Total debt

American Healthcare REIT income statement

Fiscal yearRevenueNet incomeMargin
2022$0$-81M
2023$1.9B$-71M-3.8 %
2024$2.1B$-38M-1.8 %
2025$2.3B$70M3.1 %
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.

Frequently asked questions

What is American Healthcare REIT's P/E and is the stock undervalued? What's a good P/E?

American Healthcare REIT's P/E is 84.3 (forward 57.1). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".

Is American Healthcare REIT profitable?

American Healthcare REIT has a net margin of 4.8 % (EPS 0.67). The company is profitable.

Is AHR stock expensive?

Our read: "Cheap for the growth" — P/E 57 for ~158% growth (PEG 0.4). Cross-check with growth and sector.

💬 A question about American Healthcare REIT? The JPI assistant answers using our backtest data.
Keep exploring American Healthcare REIT
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)